End-to-end therapy commercialization for the precision era

Enabled by DXRX  - The Diagnostic Network  

For over 20 years, Diaceutics has helped pharma and biotech close the gap between testing and treatment by connecting real-world data, global diagnostic expertise, and clinically trusted physician engagement through DXRX, the world’s first diagnostic commercialization platform. Our purpose is clear: ensuring every eligible patient receives the right therapy at precisely the right time.

Trusted by leading Pharma and Biotech

A partner built for modern commercialization
Working with the top 20 global pharmaceutical companies and the next wave of emerging biotechs.
20+ years of precision medicine leadership
Supporting 100s of therapy programs across oncology, rare disease, cardiology, neurology, autoimmune and more.
A global diagnostic ecosystem
A global network of laboratories across 50+ countries, enabling unparalleled visibility into the real world testing landscape.

Multi-modal insight that brings patients to the therapies they need

Successful commercialization depends on understanding where patients are tested, how physicians decide, and what stands in the way of adoption.

Diaceutics delivers this clarity through the industry’s most comprehensive AI-powered multi-modal diagnostic dataset integrating lab, genomic, clinical, claims, and SDOH insights.

Latest Resources

Whitepaper

Clinical Practice Gaps in NSCLC

Published in The Journal of Clinical Oncology, this study found that 64.4% of eligible patients are lost due to seven clinical practice gaps. Explore what’s missing and what must be fixed to ensure patients receive the right therapy.

Whitepaper

Economic & Operational Solutions for Precision Medicine

Developed by The Health and Economic Forum, this paper outlines five evidence-based recommendations to overcome the economic and operational obstacles limiting precision medicine adoption.

Webinar

Transforming Physician Identification

Learn how real time diagnostic signals and targeted physician engagement help close the gap between testing and treatment, accelerating therapy adoption and improving clinical decision-making.

Enabled by DXRX - The Diagnostic Network®

DXRX is the world’s first diagnostic commercialization platform, purpose built for precision medicine.

It integrates real-world diagnostic data from a global network of laboratories and connects precision-medicine stakeholders through a secure, standardized ecosystem. Together, they can address real-world testing challenges and help ensure every eligible patient receives the treatment they deserve.

Solutions that turn Data into Action

Unlock real-world data. 
Empower decisions. 
Accelerate therapy uptake. 
Explore our portfolio and start your journey here:

Expert Exchange

Expert Exchange connects diagnostic experts with treating physicians to drive confident prescribing through peer-to-peer education, giving your brand a trusted clinical voice to clearly explain the test–therapeutic link in a credible, non- promotional format.

DXRX Signal

DXRX Signal delivers actionable alerts within as little as 24 hours of a testing behaviour, which allows you to engage a physician whilst they are making treatment decisions.

Physician Engage

Rapidly identify, engage and educate physicians relevant to your therapy - impacting awareness, testing rates and therapy consideration.

A new model for commercializing precision therapies 

Targeted Commercialization is our integrated, precision first approach that unites real time patient insights, lab and physician behaviour intelligence, and a suite of digital and expert engagement tools. 

Strategic, agile, and built around the realities of precision medicine, it helps teams understand the market, fix testing challenges, educate physicians meaningfully, and reach eligible patients at the moments that matter - with a partner fully invested in their success.